Knight Therapeutics Stock
?
Your prediction
Knight Therapeutics Stock
Pros and Cons of Knight Therapeutics in the next few years
Pros
Cons
Performance of Knight Therapeutics vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Knight Therapeutics | 0.870% | -3.766% | 14.428% | 27.072% | 23.656% | 41.975% | 25.000% |
| Biomark Diagnostics Inc. | -4.050% | -1.744% | 4.969% | 136.364% | 22.464% | 144.928% | 0.595% |
| MicroPlanet Technology Corp | 7.140% | 11.486% | 20.438% | 63.366% | 8.553% | -3.509% | -20.673% |
| Avricore Health Inc. | 0.000% | 2.941% | -12.500% | 52.174% | 52.174% | -81.771% | -73.282% |
News
EVP of North America's Largest Full Truckload Company EVP Sells All Insider Shares
Michael K Liu, EVP - Operations at Knight-Swift (NYSE:KNX), disposed of 1,243 directly held shares in an open-market sale on Feb. 4, 2026, fully exiting his direct equity position according to a SEC
Changing Your Dog's Diet May Help the Planet More Than Changing Your Own, Study Finds
LONDON, UK / ACCESS Newswire / February 10, 2026 / Diets high in meat, eggs, and dairy products incur significant environmental costs. But a new study has revealed that, in many cases,
One Fund Just Sold $23 Million of This Major Freight Stock. Here's What Investors Should Know
On February 4, Triton Wealth Management, PLLC reported selling 481,779 shares of Knight-Swift Transportation Holdings (NYSE:KNX), an estimated $22.58 million trade based on quarterly average


